Glucose-independent glutamine metabolism via the tricarboxylic acid (TCA) cycle has been shown to be essential for malignant cell proliferation and survival within hypoxic and nutrient-depleted tumor microenvironments23; this process further highlights the initial finding in which targeting glutaminase could be an effective approach for cancer therapy. The gene discussed is GLS; the disease is neoplasm.